Cargando…

Targeting Mucosal Sites by Polymeric Immunoglobulin Receptor-directed Peptides

Polymeric immunoglobulins provide first line humoral defense at mucosal surfaces to which they are specifically transported by the polymeric immunoglobulin receptor (pIgR) on mucosal and glandular epithelial cells. Previous studies from our laboratory suggested that amino acids 402–410 of the Cα3 do...

Descripción completa

Detalles Bibliográficos
Autores principales: White, Kendra D., Capra, J. Donald
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196054/
https://www.ncbi.nlm.nih.gov/pubmed/12186846
http://dx.doi.org/10.1084/jem.20020581
_version_ 1782147985905287168
author White, Kendra D.
Capra, J. Donald
author_facet White, Kendra D.
Capra, J. Donald
author_sort White, Kendra D.
collection PubMed
description Polymeric immunoglobulins provide first line humoral defense at mucosal surfaces to which they are specifically transported by the polymeric immunoglobulin receptor (pIgR) on mucosal and glandular epithelial cells. Previous studies from our laboratory suggested that amino acids 402–410 of the Cα3 domain of dimeric IgA (dIgA) represented a potential binding site for the pIgR. Here by binding human secretory component to overlapping decapeptides of Cα3, we confirm these residues and also uncover an additional site. Furthermore, we show that the Cα3 motif appears to be sufficient to direct transport of green fluorescent protein through the pIgR-specific cellular transcytosis system. An alternative approach identified phage peptides, selected from a library by the in vitro Madin Darby Canine Kidney transcytosis assay, for pIgR-mediated transport through epithelial cells. Some transcytosis-selected peptides map to the same 402–410 pIgR-binding Cα3 site. Further in vivo studies document that at least one of these peptides is transported in a rat model measuring hepatic bile transport. In addition to identifying small peptides that are both bound and transported by the pIgR, this study provides evidence that the pIgR-mediated mucosal secretion system may represent a means of targeting small molecule therapeutics and genes to mucosal epithelial cells.
format Text
id pubmed-2196054
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21960542008-04-11 Targeting Mucosal Sites by Polymeric Immunoglobulin Receptor-directed Peptides White, Kendra D. Capra, J. Donald J Exp Med Brief Definitive Report Polymeric immunoglobulins provide first line humoral defense at mucosal surfaces to which they are specifically transported by the polymeric immunoglobulin receptor (pIgR) on mucosal and glandular epithelial cells. Previous studies from our laboratory suggested that amino acids 402–410 of the Cα3 domain of dimeric IgA (dIgA) represented a potential binding site for the pIgR. Here by binding human secretory component to overlapping decapeptides of Cα3, we confirm these residues and also uncover an additional site. Furthermore, we show that the Cα3 motif appears to be sufficient to direct transport of green fluorescent protein through the pIgR-specific cellular transcytosis system. An alternative approach identified phage peptides, selected from a library by the in vitro Madin Darby Canine Kidney transcytosis assay, for pIgR-mediated transport through epithelial cells. Some transcytosis-selected peptides map to the same 402–410 pIgR-binding Cα3 site. Further in vivo studies document that at least one of these peptides is transported in a rat model measuring hepatic bile transport. In addition to identifying small peptides that are both bound and transported by the pIgR, this study provides evidence that the pIgR-mediated mucosal secretion system may represent a means of targeting small molecule therapeutics and genes to mucosal epithelial cells. The Rockefeller University Press 2002-08-19 /pmc/articles/PMC2196054/ /pubmed/12186846 http://dx.doi.org/10.1084/jem.20020581 Text en Copyright © 2002, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Brief Definitive Report
White, Kendra D.
Capra, J. Donald
Targeting Mucosal Sites by Polymeric Immunoglobulin Receptor-directed Peptides
title Targeting Mucosal Sites by Polymeric Immunoglobulin Receptor-directed Peptides
title_full Targeting Mucosal Sites by Polymeric Immunoglobulin Receptor-directed Peptides
title_fullStr Targeting Mucosal Sites by Polymeric Immunoglobulin Receptor-directed Peptides
title_full_unstemmed Targeting Mucosal Sites by Polymeric Immunoglobulin Receptor-directed Peptides
title_short Targeting Mucosal Sites by Polymeric Immunoglobulin Receptor-directed Peptides
title_sort targeting mucosal sites by polymeric immunoglobulin receptor-directed peptides
topic Brief Definitive Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196054/
https://www.ncbi.nlm.nih.gov/pubmed/12186846
http://dx.doi.org/10.1084/jem.20020581
work_keys_str_mv AT whitekendrad targetingmucosalsitesbypolymericimmunoglobulinreceptordirectedpeptides
AT caprajdonald targetingmucosalsitesbypolymericimmunoglobulinreceptordirectedpeptides